Article(id=1329913639521333437, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913625835319315, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2018.12.012, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1531238400000, receivedDateStr=2018-07-11, revisedDate=1536595200000, revisedDateStr=2018-09-11, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005720261, onlineDateStr=2026-11-18, pubDate=1544371200000, pubDateStr=2018-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005720261, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005720261, creator=13701087609, updateTime=1795005720261, updator=13701087609, issue=Issue{id=1329913625835319315, tenantId=1146029695717560320, journalId=1319690329412173987, year='2018', volume='39', issue='12', pageStart='793', pageEnd='864', issueExtLink='null', onlineDate='null', pubDate='1544371200000', pubDateStr='2018-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005716998, creator='13701087609', updateTime=1795056425343, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330126312536126326, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913625835319315, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330126312536126327, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913625835319315, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=850, endPage=855, ext={EN=ArticleExt(id=1329913639697494206, articleId=1329913639521333437, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Progress in oxcarbazepine on the pharmacogenomics, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=

Oxcarbazepine is a new generation of antiepileptic drugs, which is approved as the monotherapy or adjunctive therapy for partial and secondarily generalised seizures. It can be used as a first-line drug for new diagnosis of epilepsy in adults. Pharmacogenomics studies had showed that the genes could affect oxcarbazepin pharmacokinetics. This review describes the oxcarbazepine from the pharmacogenomics point of view, including its action targets, catabolism, transport clearance and adverse reactions.

, authors=Chang-feng CHAI1, Rui-hong HU2, Xiao-ying BI1, *, authorsList=Chang-feng CHAI, Rui-hong HU, Xiao-ying BI, authorCompany=null, correspAuthors=Xiao-ying BI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329913639961735359, articleId=1329913639521333437, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=奥卡西平药物基因组学研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

奥卡西平是新型抗癫痫药物,可以作为局灶性癫痫治疗的一线药物,是卡马西平的衍生物,耐受性明显高于卡马西平。药物基因组学研究表明,基因可以影响奥卡西平的药物代谢动力学。本文针对奥卡西平的药物基因组学,分别从药物发挥作用的靶点、分解代谢、转运清除及不良反应进行系统综述。

, authors=柴长凤1, 胡瑞宏2, 毕晓莹1, *, authorsList=柴长凤, 胡瑞宏, 毕晓莹, authorCompany=null, correspAuthors=毕晓莹, authorNote=

柴长凤,主治医师,研究方向:癫痫的病理生理机制和抗癫痫药物的作用机制。

, correspAuthorsNote=
毕晓莹,科主任,主任医师,教授,研究方向:脑血管疾病、脑白质变性、抑郁症。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=+wvMvI7ec6pHEiV3AK/98A==, magXml=RdL/hN76KkwlrLvvC12fOA==, pdfUrl=null, pdf=aHhOkVQM0YDYXMnRPAXBkw==, pdfFileSize=1005527, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=Yw4OThZStYOKq7yHqsI7Hw==, mapNumber=null, fund=null)}, authors=[Author(id=1329913640314056903, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329913640389554377, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640314056903, language=EN, stringName=Chang-feng CHAI, firstName=Chang-feng, middleName=null, lastName=CHAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Neurology, Changhai Hospital, Navy Medical School, Shanghai 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913640456663242, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640314056903, language=CN, stringName=柴长凤, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.海军军医大学附属长海医院神经内科,上海 200433, bio={"content":"

柴长凤,主治医师,研究方向:癫痫的病理生理机制和抗癫痫药物的作用机制。

"}, bioImg=null, bioContent=

柴长凤,主治医师,研究方向:癫痫的病理生理机制和抗癫痫药物的作用机制。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913640158867648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, xref=1., ext=[AuthorCompanyExt(id=1329913640163061953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640158867648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Neurology, Changhai Hospital, Navy Medical School, Shanghai 200433), AuthorCompanyExt(id=1329913640171450562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640158867648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.海军军医大学附属长海医院神经内科,上海 200433)])]), Author(id=1329913640557326540, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329913640632824014, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640557326540, language=EN, stringName=Rui-hong HU, firstName=Rui-hong, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Rehabilitation Medicine, The First People's Hospital of Kashgar District, Kashgar 844000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913640708321487, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640557326540, language=CN, stringName=胡瑞宏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.新疆喀什地区第一人民医院康复医学科,喀什 844000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913640242753731, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, xref=2., ext=[AuthorCompanyExt(id=1329913640251142340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640242753731, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rehabilitation Medicine, The First People's Hospital of Kashgar District, Kashgar 844000, China), AuthorCompanyExt(id=1329913640255336645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640242753731, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.新疆喀什地区第一人民医院康复医学科,喀什 844000)])]), Author(id=1329913640838344913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329913640913842387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640838344913, language=EN, stringName=Xiao-ying BI, firstName=Xiao-ying, middleName=null, lastName=BI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Neurology, Changhai Hospital, Navy Medical School, Shanghai 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913640980951252, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640838344913, language=CN, stringName=毕晓莹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.海军军医大学附属长海医院神经内科,上海 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913640158867648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, xref=1., ext=[AuthorCompanyExt(id=1329913640163061953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640158867648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Neurology, Changhai Hospital, Navy Medical School, Shanghai 200433), AuthorCompanyExt(id=1329913640171450562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640158867648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.海军军医大学附属长海医院神经内科,上海 200433)])])], keywords=[Keyword(id=1329913641069031637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, language=EN, orderNo=1, keyword=oxcarbazepine), Keyword(id=1329913641123557590, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, language=EN, orderNo=2, keyword=antiepileptic drug), Keyword(id=1329913641182277847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, language=EN, orderNo=3, keyword=pharmacogenomics), Keyword(id=1329913641236803800, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, language=CN, orderNo=1, keyword=奥卡西平), Keyword(id=1329913641295524057, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, language=CN, orderNo=2, keyword=抗癫痫药物), Keyword(id=1329913641358438618, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, language=CN, orderNo=3, keyword=药物基因组学)], refs=[Reference(id=1329913641433936091, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Gamble C, Williamson PR, Chadwick DW, et al. A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy[J]. Neurology, 2006, 66(9): 1310-1317., articleTitle=null, refAbstract=null), Reference(id=1329913641496850652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials[J]. Pharmacotherapy, 2000, 20(8 Pt 2): 152-158., articleTitle=null, refAbstract=null), Reference(id=1329913641563959517, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Zou XM, Chen JN, An DM, et al. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy[J]. Seizure, 2015, 29: 81-85., articleTitle=null, refAbstract=null), Reference(id=1329913641622679774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Schmidt D, Elger CE. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?[J]. Epilepsy Behav, 2004, 5(5): 627-635., articleTitle=null, refAbstract=null), Reference(id=1329913641685594335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Franco V, Perucca E. The pharmacogenomics of epilepsy[J]. Expert Rev Neurother, 2015, 15(10): 1161-1170., articleTitle=null, refAbstract=null), Reference(id=1329913641777869024, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Ma CL, Wu XY, Jiao Z, et al. SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy[J]. Pharmacogenomics, 2015, 16(4): 347-360., articleTitle=null, refAbstract=null), Reference(id=1329913641849172193, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Breton H, Cociglio M, Bressolle F, et al. Liquidchromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2005, 828(1-2): 80-90., articleTitle=null, refAbstract=null), Reference(id=1329913641920475362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Neels HM, Sierens AC, Naelaerts K, et al. Therapeutic drugmonitoring of old and newer anti-epileptic drugs[J]. Clin Chem Lab Med, 2004, 42(11): 1228-1255., articleTitle=null, refAbstract=null), Reference(id=1329913641991778531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Ambrosio AF, Soares-Da-Silva P, Carvalho CM, et al. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024[J]. Neurochem Res, 2002, 27(1-2): 121-130., articleTitle=null, refAbstract=null), Reference(id=1329913642054693092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Ragsdale DS. How do mutant Nav1.1 sodium channels cause epilepsy?[J]. Brain Res Rev, 2008, 58(1): 149-159., articleTitle=null, refAbstract=null), Reference(id=1329913642121801957, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Catterall WA, Kalume F, Oakley JC. NaV1.1 channels and epilepsy[J]. J Physiol, 2010, 588(Pt 11): 1849-1859., articleTitle=null, refAbstract=null), Reference(id=1329913642176327910, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Wellington K, Goa KL. Oxcarbazepine: an update of its effcacy in the management of epilepsy[J]. CNS Drugs, 2001, 15(2): 137-163., articleTitle=null, refAbstract=null), Reference(id=1329913642235048167, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Court MH, Duan SX, Guillemette C, et al. Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9[J]. Drug Metab Dispos, 2002, 30(11): 1257-1265., articleTitle=null, refAbstract=null), Reference(id=1329913642293768424, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Court MH, Hao Q, Krishnaswamy S, et al. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver[J]. J Pharmacol Exp Ther, 2004, 310(2): 656-665., articleTitle=null, refAbstract=null), Reference(id=1329913642348294377, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Gonzalez FJ. Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription[J]. Drug Metab Pharmacok, 2008, 23(1): 2-7., articleTitle=null, refAbstract=null), Reference(id=1329913642402820330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou YF, Wang XD, Li HL, et al. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with lamotrigine trough concentrations in epilepsy patients[J]. Drug Metab Pharmacokinet, 2015, 30(4): 282-287., articleTitle=null, refAbstract=null), Reference(id=1329913642486706411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Flesch G. Overview of the clinical pharmacokinetics of oxcarbazepine[J]. Clin Drug Investig, 2004, 24(4): 185-203., articleTitle=null, refAbstract=null), Reference(id=1329913642553815276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Högler W, Wudy SA, Luef G, et al. Oxcarbazepine accelerates cortisol elimination via cytochrome P450 3A4 induction[J]. Arch Dis Child, 2010, 95(12): 1065-1065., articleTitle=null, refAbstract=null), Reference(id=1329913642612535533, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Andreasen AH, Brosen K, Damkier P. A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on CYP3A4[J]. Epilepsia, 2007, 48(3): 490-496., articleTitle=null, refAbstract=null), Reference(id=1329913642675450094, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Sugiyama I, Murayama N, Kuroki A, et al. Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine usinghuman hepatocytes and HepaRG cells[J]. Xenobiotica, 2016, 46(9): 765-774., articleTitle=null, refAbstract=null), Reference(id=1329913642734170351, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Mackenzie PI, Bock KW, Burchell B, et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily[J]. Pharmacogenet Genomics, 2005, 15(10): 677-685., articleTitle=null, refAbstract=null), Reference(id=1329913642792890608, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Finel M, Li X, Gardner-Stephen D, et al. Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity[J]. J Pharmacol Exp Ther, 2005, 315(3): 1143-1149., articleTitle=null, refAbstract=null), Reference(id=1329913642855805169, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Dallas S, Miller DS, Bendayan R. Multidrug resistance-associated proteins: expression and function in the central nervous system[J]. Pharmacol Rev, 2006, 58(2): 140-161., articleTitle=null, refAbstract=null), Reference(id=1329913642910331122, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Giacomini KM, Huang SM, Tweedie DJ, et al. Membrane transporters in drug development[J]. Nat Rev Drug Discov, 2010, 9(3): 215-236., articleTitle=null, refAbstract=null), Reference(id=1329913642969051379, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Tazzite A, Kassogue Y, Diakité B, et al. Association between ABCB1 C3435T polymorphism and breast cancer risk: a Moroccan casecontrol study and meta-analysis[J]. Bio Med Cent Genet, 2016, 17(1): 126-126., articleTitle=null, refAbstract=null), Reference(id=1329913643023577332, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Chouchi M, Kaabachi W, Klaa H, et al. Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis[J]. Bio Med Cent Neurol, 2017, 17(1): 32-32., articleTitle=null, refAbstract=null), Reference(id=1329913643086491893, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=He X, Hazarika S, Masse G, et al. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion[J]. Br J Clin Pharmacol, 2009, 68(5): 721-730., articleTitle=null, refAbstract=null), Reference(id=1329913643157795062, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang C, Zuo Z, Kwan P, et al. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein[J]. Epilepsia, 2011, 52(10): 1894-1904., articleTitle=null, refAbstract=null), Reference(id=1329913643216515319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Ufer M, von Stülpnagel C, Muhle H, et al. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy[J]. Pharmacogenet Genomics, 2011, 21(10): 624-630., articleTitle=null, refAbstract=null), Reference(id=1329913643275235576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang P, Yin T, Ma HY, et al. First analysis of the association between CYP3A4/5, ABCB1 genetic polymorphisms and oxcarbazepine metabolism and transport in Chinese epileptic patients with oxcarbazepine monotherapy and bitherapy[J]. J Pharm Pharm Sci, 2015, 18(2): 258-265., articleTitle=null, refAbstract=null), Reference(id=1329913643338150137, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Puranik YG, Birnbaum AK, Marino SE, et al. Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy[J]. Pharmacogenomics, 2013, 14(1): 35-45., articleTitle=null, refAbstract=null), Reference(id=1329913643405259002, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Lu Y, Fang Y, Wu X, et al. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy[J]. Eur J Clin Pharmacol, 2017, 73(3): 307-315., articleTitle=null, refAbstract=null), Reference(id=1329913643484950779, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Shen C, Zhang B, Liu Z, et al. Effects of ABCB1, ABCC2, UGT2B7 and HNF4 genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy[J]. Seizure, 2017, 51: 102-106., articleTitle=null, refAbstract=null), Reference(id=1329913643552059644, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Alvestad S, Lydersen S, Brodtkorb E. Rash from antiepileptic drugs: influence by gender, age, and learning disability[J]. Epilepsia, 2007, 48(7): 1360-1365., articleTitle=null, refAbstract=null), Reference(id=1329913643623362813, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Toledano R, Gil-Nagel A. Adverse effects of antiepileptic drugs[J]. Semin Neurol, 2008, 28: 317-327., articleTitle=null, refAbstract=null), Reference(id=1329913643686277374, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Kaufman DW, Shapiro S. Epidemiological assessment of drug-induced disease[J]. Lancet, 2000, 356(9238): 1339-1343., articleTitle=null, refAbstract=null), Reference(id=1329913643749191935, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Arif H, Buchsbaum R, Weintraub D, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs[J]. Neurology, 2007, 68(20): 1701-1709., articleTitle=null, refAbstract=null), Reference(id=1329913643807912192, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome[J]. Nature, 2004, 428: 486-486., articleTitle=null, refAbstract=null), Reference(id=1329913643866632449, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Pan RY, Dao RL, Hung SI, et al. Pharmacogenomic advances in the prediction and prevention of cutaneous idiosyncratic drug reactions[J]. Clin Pharmacol Ther, 2017, 102(1): 86-97., articleTitle=null, refAbstract=null), Reference(id=1329913643942129922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Tangamornsuksan W, Chaiyakunapruk N, Somkrua R, et al. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens–Johnson syndrome and toxic epidermal necrolysis[J]. J Am Med Assoc Dermatol, 2013, 149(9): 1025-1032., articleTitle=null, refAbstract=null), Reference(id=1329913644005044483, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Shorvon S. Oxcarbazepine: a review[J]. Seizure, 2000, 9(2): 75-79., articleTitle=null, refAbstract=null), Reference(id=1329913644076347652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang XQ, Lang SY, Shi XB, et al. Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3 793 Chinese patients with epilepsy[J]. Clin Neurol Neurosurg, 2012, 114(7): 862-865., articleTitle=null, refAbstract=null), Reference(id=1329913644135067909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen YC, Chu CY, Hsiao CH. Oxcarbazepine-induced Stevens-Johnson syndrome in a patient with HLA-B*1502 genotype[J]. J Eur Acad Dermatol Venereol, 2009, 23(6): 702-703., articleTitle=null, refAbstract=null), Reference(id=1329913644202176774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Hung SI, Chung WH, Liu ZS, et al. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese[J]. Pharmacogenomics, 2010, 11(3): 349-356., articleTitle=null, refAbstract=null), Reference(id=1329913644265091335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Hu FY, Wu XT, An DM, et al. Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population[J]. Seizure, 2011, 20(2): 160-162., articleTitle=null, refAbstract=null), Reference(id=1329913644328005896, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=He N, Min FL, Shi YW, et al. Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles[J]. Seizure, 2012, 21(8): 614-618., articleTitle=null, refAbstract=null), Reference(id=1329913644378337545, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=Lv YD, Min FL, Liao WP, et al. The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a Northern Han Chinese population[J]. Bio Med Cent Neurol, 2013, 13: 75-75., articleTitle=null, refAbstract=null), Reference(id=1329913644449640714, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen CB, Hsiao YH, Wu T, et al. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians[J]. Neurology, 2017, 88(1): 78-86., articleTitle=null, refAbstract=null), Reference(id=1329913644516749579, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu Y, Yu Y, Nie X, et al. Association between HLA-B*15:02 and oxcarbazepine-induced cutaneous adverse reaction: a meta-analysis[J]. Pharmacogenomics, 2018, 19(6): 547-552., articleTitle=null, refAbstract=null), Reference(id=1329913644571275532, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=Moon J, Kim TJ, Lim JA, et al. HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption[J]. Epilepsia, 2016, 57(11): 1879-1886., articleTitle=null, refAbstract=null), Reference(id=1329913644634190093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=Berghuis B, van der Palen J, de Haan GJ, et al. Carbamazepine and oxcarbazepine-induced hyponatremia in people with epilepsy[J]. Epilepsia, 2017, 58(7): 1227-1233., articleTitle=null, refAbstract=null), Reference(id=1329913644705493262, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=Berghuis B, de Haan GJ, van den Broek MP, et al. Epidemiology, pathophysiology and putative genetic basis of carbamazepine and oxcarbazepine-induced hyponatremia[J]. Eur J Neurol, 2016, 23(9): 1393-1399., articleTitle=null, refAbstract=null), Reference(id=1329913644780990735, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=Juul KV, Bichet DG, Nielsen S, et al. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors[J]. Am J Physiol Renal Physiol, 2014, 306(9): F931-F940., articleTitle=null, refAbstract=null), Reference(id=1329913644856488208, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=Lin CH, Lu CH, Wang FJ, et al. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy[J]. Clin Neuropharmacol, 2010, 33(6): 293-296., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329913640158867648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, xref=1., ext=[AuthorCompanyExt(id=1329913640163061953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640158867648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Neurology, Changhai Hospital, Navy Medical School, Shanghai 200433), AuthorCompanyExt(id=1329913640171450562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640158867648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.海军军医大学附属长海医院神经内科,上海 200433)]), AuthorCompany(id=1329913640242753731, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, xref=2., ext=[AuthorCompanyExt(id=1329913640251142340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640242753731, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rehabilitation Medicine, The First People's Hospital of Kashgar District, Kashgar 844000, China), AuthorCompanyExt(id=1329913640255336645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640242753731, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.新疆喀什地区第一人民医院康复医学科,喀什 844000)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.12.012, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.12.012, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2018.12.012, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2018.12.012, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1544371200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
奥卡西平药物基因组学研究进展
柴长凤 1 , 胡瑞宏 2 , 毕晓莹 1, *
世界临床药物 | 综述评论 2018,39(12): 850-855
收起
收藏切换
世界临床药物 |综述评论 2018 , 39 (12) : 850 -855
奥卡西平药物基因组学研究进展
全屏
[Author(id=1329913640314056903, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329913640389554377, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640314056903, language=EN, stringName=Chang-feng CHAI, firstName=Chang-feng, middleName=null, lastName=CHAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Neurology, Changhai Hospital, Navy Medical School, Shanghai 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913640456663242, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640314056903, language=CN, stringName=柴长凤, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.海军军医大学附属长海医院神经内科,上海 200433, bio={"content":"

柴长凤,主治医师,研究方向:癫痫的病理生理机制和抗癫痫药物的作用机制。

"}, bioImg=null, bioContent=

柴长凤,主治医师,研究方向:癫痫的病理生理机制和抗癫痫药物的作用机制。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913640158867648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, xref=1., ext=[AuthorCompanyExt(id=1329913640163061953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640158867648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Neurology, Changhai Hospital, Navy Medical School, Shanghai 200433), AuthorCompanyExt(id=1329913640171450562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640158867648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.海军军医大学附属长海医院神经内科,上海 200433)])]), Author(id=1329913640557326540, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329913640632824014, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640557326540, language=EN, stringName=Rui-hong HU, firstName=Rui-hong, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Rehabilitation Medicine, The First People's Hospital of Kashgar District, Kashgar 844000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913640708321487, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640557326540, language=CN, stringName=胡瑞宏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.新疆喀什地区第一人民医院康复医学科,喀什 844000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913640242753731, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, xref=2., ext=[AuthorCompanyExt(id=1329913640251142340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640242753731, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rehabilitation Medicine, The First People's Hospital of Kashgar District, Kashgar 844000, China), AuthorCompanyExt(id=1329913640255336645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640242753731, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.新疆喀什地区第一人民医院康复医学科,喀什 844000)])]), Author(id=1329913640838344913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329913640913842387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640838344913, language=EN, stringName=Xiao-ying BI, firstName=Xiao-ying, middleName=null, lastName=BI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Neurology, Changhai Hospital, Navy Medical School, Shanghai 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913640980951252, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, authorId=1329913640838344913, language=CN, stringName=毕晓莹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.海军军医大学附属长海医院神经内科,上海 200433, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913640158867648, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, xref=1., ext=[AuthorCompanyExt(id=1329913640163061953, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640158867648, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Neurology, Changhai Hospital, Navy Medical School, Shanghai 200433), AuthorCompanyExt(id=1329913640171450562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913639521333437, companyId=1329913640158867648, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.海军军医大学附属长海医院神经内科,上海 200433)])])]
柴长凤1, 胡瑞宏2, 毕晓莹1, *
作者信息
  • 1.海军军医大学附属长海医院神经内科,上海 200433
  • 2.新疆喀什地区第一人民医院康复医学科,喀什 844000
通讯作者:
毕晓莹,科主任,主任医师,教授,研究方向:脑血管疾病、脑白质变性、抑郁症。
作者简介:

柴长凤,主治医师,研究方向:癫痫的病理生理机制和抗癫痫药物的作用机制。

Progress in oxcarbazepine on the pharmacogenomics
Chang-feng CHAI1, Rui-hong HU2, Xiao-ying BI1, *
Affiliations
  • 1.Department of Neurology, Changhai Hospital, Navy Medical School, Shanghai 200433
  • 2.Department of Rehabilitation Medicine, The First People's Hospital of Kashgar District, Kashgar 844000, China
出版时间: 2018-12-10 doi: 10.13683/j.wph.2018.12.012
文章导航
收藏切换

奥卡西平是新型抗癫痫药物,可以作为局灶性癫痫治疗的一线药物,是卡马西平的衍生物,耐受性明显高于卡马西平。药物基因组学研究表明,基因可以影响奥卡西平的药物代谢动力学。本文针对奥卡西平的药物基因组学,分别从药物发挥作用的靶点、分解代谢、转运清除及不良反应进行系统综述。

奥卡西平  /  抗癫痫药物  /  药物基因组学

Oxcarbazepine is a new generation of antiepileptic drugs, which is approved as the monotherapy or adjunctive therapy for partial and secondarily generalised seizures. It can be used as a first-line drug for new diagnosis of epilepsy in adults. Pharmacogenomics studies had showed that the genes could affect oxcarbazepin pharmacokinetics. This review describes the oxcarbazepine from the pharmacogenomics point of view, including its action targets, catabolism, transport clearance and adverse reactions.

oxcarbazepine  /  antiepileptic drug  /  pharmacogenomics
柴长凤, 胡瑞宏, 毕晓莹. 奥卡西平药物基因组学研究进展. 世界临床药物, 2018 , 39 (12) : 850 -855 . DOI: 10.13683/j.wph.2018.12.012
Chang-feng CHAI, Rui-hong HU, Xiao-ying BI. Progress in oxcarbazepine on the pharmacogenomics[J]. World Clinical Drug, 2018 , 39 (12) : 850 -855 . DOI: 10.13683/j.wph.2018.12.012

参考文献 引证文献
排序方式:
[1]
Gamble C, Williamson PR, Chadwick DW, et al. A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy[J]. Neurology, 2006, 66(9): 1310-1317.
[2]
Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials[J]. Pharmacotherapy, 2000, 20(8 Pt 2): 152-158.
[3]
Zou XM, Chen JN, An DM, et al. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy[J]. Seizure, 2015, 29: 81-85.
[4]
Schmidt D, Elger CE. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?[J]. Epilepsy Behav, 2004, 5(5): 627-635.
[5]
Franco V, Perucca E. The pharmacogenomics of epilepsy[J]. Expert Rev Neurother, 2015, 15(10): 1161-1170.
[6]
Ma CL, Wu XY, Jiao Z, et al. SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy[J]. Pharmacogenomics, 2015, 16(4): 347-360.
[7]
Breton H, Cociglio M, Bressolle F, et al. Liquidchromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2005, 828(1-2): 80-90.
[8]
Neels HM, Sierens AC, Naelaerts K, et al. Therapeutic drugmonitoring of old and newer anti-epileptic drugs[J]. Clin Chem Lab Med, 2004, 42(11): 1228-1255.
[9]
Ambrosio AF, Soares-Da-Silva P, Carvalho CM, et al. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024[J]. Neurochem Res, 2002, 27(1-2): 121-130.
[10]
Ragsdale DS. How do mutant Nav1.1 sodium channels cause epilepsy?[J]. Brain Res Rev, 2008, 58(1): 149-159.
[11]
Catterall WA, Kalume F, Oakley JC. NaV1.1 channels and epilepsy[J]. J Physiol, 2010, 588(Pt 11): 1849-1859.
[12]
Wellington K, Goa KL. Oxcarbazepine: an update of its effcacy in the management of epilepsy[J]. CNS Drugs, 2001, 15(2): 137-163.
[13]
Court MH, Duan SX, Guillemette C, et al. Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9[J]. Drug Metab Dispos, 2002, 30(11): 1257-1265.
[14]
Court MH, Hao Q, Krishnaswamy S, et al. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver[J]. J Pharmacol Exp Ther, 2004, 310(2): 656-665.
[15]
Gonzalez FJ. Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription[J]. Drug Metab Pharmacok, 2008, 23(1): 2-7.
[16]
Zhou YF, Wang XD, Li HL, et al. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with lamotrigine trough concentrations in epilepsy patients[J]. Drug Metab Pharmacokinet, 2015, 30(4): 282-287.
[17]
Flesch G. Overview of the clinical pharmacokinetics of oxcarbazepine[J]. Clin Drug Investig, 2004, 24(4): 185-203.
[18]
Högler W, Wudy SA, Luef G, et al. Oxcarbazepine accelerates cortisol elimination via cytochrome P450 3A4 induction[J]. Arch Dis Child, 2010, 95(12): 1065-1065.
[19]
Andreasen AH, Brosen K, Damkier P. A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on CYP3A4[J]. Epilepsia, 2007, 48(3): 490-496.
[20]
Sugiyama I, Murayama N, Kuroki A, et al. Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine usinghuman hepatocytes and HepaRG cells[J]. Xenobiotica, 2016, 46(9): 765-774.
[21]
Mackenzie PI, Bock KW, Burchell B, et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily[J]. Pharmacogenet Genomics, 2005, 15(10): 677-685.
[22]
Finel M, Li X, Gardner-Stephen D, et al. Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity[J]. J Pharmacol Exp Ther, 2005, 315(3): 1143-1149.
[23]
Dallas S, Miller DS, Bendayan R. Multidrug resistance-associated proteins: expression and function in the central nervous system[J]. Pharmacol Rev, 2006, 58(2): 140-161.
[24]
Giacomini KM, Huang SM, Tweedie DJ, et al. Membrane transporters in drug development[J]. Nat Rev Drug Discov, 2010, 9(3): 215-236.
[25]
Tazzite A, Kassogue Y, Diakité B, et al. Association between ABCB1 C3435T polymorphism and breast cancer risk: a Moroccan casecontrol study and meta-analysis[J]. Bio Med Cent Genet, 2016, 17(1): 126-126.
[26]
Chouchi M, Kaabachi W, Klaa H, et al. Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis[J]. Bio Med Cent Neurol, 2017, 17(1): 32-32.
[27]
He X, Hazarika S, Masse G, et al. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion[J]. Br J Clin Pharmacol, 2009, 68(5): 721-730.
[28]
Zhang C, Zuo Z, Kwan P, et al. In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein[J]. Epilepsia, 2011, 52(10): 1894-1904.
[29]
Ufer M, von Stülpnagel C, Muhle H, et al. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy[J]. Pharmacogenet Genomics, 2011, 21(10): 624-630.
[30]
Wang P, Yin T, Ma HY, et al. First analysis of the association between CYP3A4/5, ABCB1 genetic polymorphisms and oxcarbazepine metabolism and transport in Chinese epileptic patients with oxcarbazepine monotherapy and bitherapy[J]. J Pharm Pharm Sci, 2015, 18(2): 258-265.
[31]
Puranik YG, Birnbaum AK, Marino SE, et al. Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy[J]. Pharmacogenomics, 2013, 14(1): 35-45.
[32]
Lu Y, Fang Y, Wu X, et al. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy[J]. Eur J Clin Pharmacol, 2017, 73(3): 307-315.
[33]
Shen C, Zhang B, Liu Z, et al. Effects of ABCB1, ABCC2, UGT2B7 and HNF4 genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy[J]. Seizure, 2017, 51: 102-106.
[34]
Alvestad S, Lydersen S, Brodtkorb E. Rash from antiepileptic drugs: influence by gender, age, and learning disability[J]. Epilepsia, 2007, 48(7): 1360-1365.
[35]
Toledano R, Gil-Nagel A. Adverse effects of antiepileptic drugs[J]. Semin Neurol, 2008, 28: 317-327.
[36]
Kaufman DW, Shapiro S. Epidemiological assessment of drug-induced disease[J]. Lancet, 2000, 356(9238): 1339-1343.
[37]
Arif H, Buchsbaum R, Weintraub D, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs[J]. Neurology, 2007, 68(20): 1701-1709.
[38]
Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome[J]. Nature, 2004, 428: 486-486.
[39]
Pan RY, Dao RL, Hung SI, et al. Pharmacogenomic advances in the prediction and prevention of cutaneous idiosyncratic drug reactions[J]. Clin Pharmacol Ther, 2017, 102(1): 86-97.
[40]
Tangamornsuksan W, Chaiyakunapruk N, Somkrua R, et al. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens–Johnson syndrome and toxic epidermal necrolysis[J]. J Am Med Assoc Dermatol, 2013, 149(9): 1025-1032.
[41]
Shorvon S. Oxcarbazepine: a review[J]. Seizure, 2000, 9(2): 75-79.
[42]
Wang XQ, Lang SY, Shi XB, et al. Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3 793 Chinese patients with epilepsy[J]. Clin Neurol Neurosurg, 2012, 114(7): 862-865.
[43]
Chen YC, Chu CY, Hsiao CH. Oxcarbazepine-induced Stevens-Johnson syndrome in a patient with HLA-B*1502 genotype[J]. J Eur Acad Dermatol Venereol, 2009, 23(6): 702-703.
[44]
Hung SI, Chung WH, Liu ZS, et al. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese[J]. Pharmacogenomics, 2010, 11(3): 349-356.
[45]
Hu FY, Wu XT, An DM, et al. Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population[J]. Seizure, 2011, 20(2): 160-162.
[46]
He N, Min FL, Shi YW, et al. Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles[J]. Seizure, 2012, 21(8): 614-618.
[47]
Lv YD, Min FL, Liao WP, et al. The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a Northern Han Chinese population[J]. Bio Med Cent Neurol, 2013, 13: 75-75.
[48]
Chen CB, Hsiao YH, Wu T, et al. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians[J]. Neurology, 2017, 88(1): 78-86.
[49]
Liu Y, Yu Y, Nie X, et al. Association between HLA-B*15:02 and oxcarbazepine-induced cutaneous adverse reaction: a meta-analysis[J]. Pharmacogenomics, 2018, 19(6): 547-552.
[50]
Moon J, Kim TJ, Lim JA, et al. HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption[J]. Epilepsia, 2016, 57(11): 1879-1886.
[51]
Berghuis B, van der Palen J, de Haan GJ, et al. Carbamazepine and oxcarbazepine-induced hyponatremia in people with epilepsy[J]. Epilepsia, 2017, 58(7): 1227-1233.
[52]
Berghuis B, de Haan GJ, van den Broek MP, et al. Epidemiology, pathophysiology and putative genetic basis of carbamazepine and oxcarbazepine-induced hyponatremia[J]. Eur J Neurol, 2016, 23(9): 1393-1399.
[53]
Juul KV, Bichet DG, Nielsen S, et al. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors[J]. Am J Physiol Renal Physiol, 2014, 306(9): F931-F940.
[54]
Lin CH, Lu CH, Wang FJ, et al. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy[J]. Clin Neuropharmacol, 2010, 33(6): 293-296.
2018年第39卷第12期
13
2
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2018.12.012
  • 接收时间:2018-07-11
  • 首发时间:2026-11-18
  • 出版时间:2018-12-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2018-07-11
  • 修回日期:2018-09-11
基金
作者信息
    1.海军军医大学附属长海医院神经内科,上海 200433
    2.新疆喀什地区第一人民医院康复医学科,喀什 844000

通讯作者:

毕晓莹,科主任,主任医师,教授,研究方向:脑血管疾病、脑白质变性、抑郁症。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.12.012
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏